Requisite Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Hold
238
0.04% 103
2025
Q4
$256K Sell
238
-124
-34% -$119K 0.05% 99
2025
Q3
$276K Buy
+362
New +$269K 0.05% 238
2025
Q1
Sell
-508
Closed -$392K 91
2024
Q4
$392K Buy
508
+44
+9% +$36.4K 0.08% 64
2024
Q3
$411K Hold
464
0.09% 50
2024
Q2
$420K Sell
464
-836
-64% -$669K 0.1% 53
2024
Q1
$1.01M Hold
1,300
0.22% 27
2023
Q4
$758K Hold
1,300
0.19% 31
2023
Q3
$698K Buy
+1,300
New +$670K 0.18% 26

Other funds holding LLY

Requisite Capital Management's LLY Position: Q1 2026 in Review

Requisite Capital Management held its Eli Lilly (LLY) position steady in Q1 2026 at 238 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #103.

Requisite Capital Management first reported a position in LLY in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.01M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Requisite Capital Management held 238 shares of Eli Lilly worth $219K as of Q1 2026.
  • Requisite Capital Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.04% of Requisite Capital Management's portfolio in Q1 2026, its #103 holding.
  • Requisite Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 9 quarters since.
  • Requisite Capital Management's Eli Lilly position peaked at $1.01M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.